Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over, manufacturer GSK says.
| |
| |
|
| | | | Subscribe to our other newsletters | | | | A curated newsletter on the day’s most important news. | The biggest headlines to start your morning. | A twice-weekly update on the latest from Parliament Hill. |
| | |
|
